2026 March

Antimicrobial resistance is no longer just a clinical threat, but a force reshaping the entire healthcare system.
From research and manufacturing to regulation and economic models, every layer of the pharmaceutical ecosystem is under growing pressure.

This issue explores AMR as a systemic phenomenon, capable of disrupting established balances and imposing new logics of development, investment and responsibility.
It is not only a scientific challenge, but an industrial and cultural transformation.

---

Issue 2
March, 2026